Researchers are excited about the medication , a groundbreaking dual agonist showing significant outcomes in early trials for body reduction . It works by targeting both systems: GLP-1 and GIP, which , https://jayavhvj033813.onzeblog.com/40962636/the-new-prospect-for-size-reduction